How foods can impact your gut health
Saturday is "National Food is Medicine Day" and many Americans deal with a plethora of health issues. LiveNOW from FOX host Christy Matino spoke to Dr. Joan Salge Blake, a clinical assistant professor and dietetics internship director at Boston University’s Sargent College of Health and Rehabilitation Sciences on this issue. The Brief
A study from The BMJ found 44% of participants reversed type 2 diabetes with a calorie-restricted diet and dapagliflozin.
Remission was defined as normal blood sugar levels maintained for two months after stopping diabetic medications.
The combination strategy also improved weight loss, insulin resistance, and cholesterol levels.
A new clinical trial in The BMJ found that combining calorie restriction with the diabetes drug dapagliflozin reversed type 2 diabetes in nearly half of participants.
The approach also improved weight, blood pressure, and cholesterol, offering a practical solution for managing this widespread condition.
The backstory:
Type 2 diabetes remission has traditionally been linked to significant weight loss, often achieved through intense calorie restriction or bariatric surgery. However, the new study offers an alternative by combining moderate calorie reduction with dapagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor.Dapagliflozin helps regulate blood sugar by promoting glucose excretion through urine, reducing reliance on insulin. This approach, paired with cutting 500 to 750 calories daily and physical activity, allowed nearly 44% of participants to achieve remission after one year. FILE – Different kinds of vegetables, including paprikas, zucchini, onions and tomatoes, lie on display. (Photo by Sean Gallup/Getty Images) By the numbers:The trial included over 300 adults in China with type 2 diabetes diagnosed within the past six years. Participants were randomly assigned to either a dapagliflozin group or a placebo group while adhering to a calorie-restricted diet and physical activity routine.Key findings: 44% in the dapagliflozin group versus 28% in the placebo group. Participants taking dapagliflozin lost an average of 11 pounds, compared to 7 pounds in the placebo group. Dapagliflozin patients also had better insulin sensitivity, lower cholesterol, and improved blood pressure. What they’re saying:Experts have called the results promising, noting the potential for wider accessibility compared […]
Combination of medication, diet could reverse type 2 diabetes, study finds
